KLF17 and gastric cancer: KLF17 is poorly expressed in GCSCs, and its overexpression reportedly inhibits epithelial‒mesenchymal transition in gastric cancer cells through the TGF-β/Smad pathway, thereby reducing the invasion and migration of these cells53,54.